← Leaderboards
Rachel Fynvola Tyndale
University Of Pennsylvania
$3,465,511
Attributed
$3,465,511
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.8M · FY2010–22$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$16,138,849 · 4
By mechanism
U01$14,372,271 · 2
R01$1,476,221 · 1
R21$290,357 · 1
Top collaborators
- Caryn Lerman7 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Robert Gross$16,941,227
- Jason D Christie$28,582,304
- Ruthie Wittenberg$80,137
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticBrainVariantSmokingSmokerResponseMetabolismNicotineRewardsReportingSourceDrug KineticsNicotine DependenceEnzymesCravingCyp2b6 GeneSmokeSeveritiesPlacebosClinical TrialsNicotine WithdrawalNicotinic ReceptorsBaseRelapse
Grant awards (20)
Variable brain oxycodone metabolism alters drug effect$289,509
R01 · FY2022 · DA · contact PI
Variable brain oxycodone metabolism alters drug effect$287,022
R01 · FY2021 · DA · contact PI
Variable brain oxycodone metabolism alters drug effect$287,022
R01 · FY2020 · DA · contact PI
Variable brain oxycodone metabolism alters drug effect$306,334
R01 · FY2019 · DA · contact PI
Variable brain oxycodone metabolism alters drug effect$306,334
R01 · FY2018 · DA · contact PI
Pharmacogenetics of Nicotine Addiction Treatment$1,659,442
U01 · FY2014 · DA
University of Toronto Coordinating Genetics Core & Clinical Trial Site$324,580
U01 · FY2014 · DA · contact PI
Pharmacogenetics of Nicotine Addiction Treatment$1,871,783
U01 · FY2013 · DA
Pharmacogenetics of Nicotine Addiction Treatment$678,397
U01 · FY2013 · DA
University of Toronto Coordinating Genetics Core & Clinical Trial Site$240,110
U01 · FY2013 · DA · contact PI
Pharmacogenetics of Nicotine Addiction Treatment$2,635,621
U01 · FY2012 · DA
Pharmacogenetics of Nicotine Addiction Treatment$722,396
U01 · FY2012 · DA
University of Toronto Coordinating Genetics Core & Clinical Trial Site$349,373
U01 · FY2012 · DA · contact PI
University of Toronto Coordinating Genetics Core & Clinical Trial Site$103,200
U01 · FY2012 · DA · contact PI
Pharmacogenetics of Nicotine Addiction Treatment$2,705,047
U01 · FY2011 · DA
University of Toronto Coordinating Genetics Core & Clinical Trial Site$357,667
U01 · FY2011 · DA · contact PI
Reduced CYP2B6 metabolism influences smoking initiation and treatment response: i$134,757
R21 · FY2011 · DA · contact PI
Pharmacogenetics of Nicotine Addiction Treatment$2,400,652
U01 · FY2010 · DA
University of Toronto Coordinating Genetics Core & Clinical Trial Site$324,003
U01 · FY2010 · DA · contact PI
Reduced CYP2B6 metabolism influences smoking initiation and treatment response: i$155,600
R21 · FY2010 · DA · contact PI